If you register now, then you can choose to watch it live or later. The webinar will be available later, but without any CME points.

>LIVE:  1 August 2026, Saturday 10:00 am (UK time zone)

Agenda

• 40 minutes presentation and then 20 minutes Q&A with the host Nathan Nagel
• Mechanisms linking glucose-lowering therapy and weight change
• Cardiometabolic and renal outcomes of SGLT2 inhibitors

• • How to prescribe safely: eGFR thresholds and sick-day rules

  • DPP-4 inhibitors and TZDs: managing expectations for weight impact

  • Ethnic variations in response and safety

  • Combining SGLT2 inhibitors with metformin for optimal results